About Healixia
Healixia is the result of a convergence between ACRP.be, BAPU, BeAPP and BRAS which will continue as a joint new member association.
Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.
Healixia provides development, education, training and networking opportunities across all members and disciplines. Healixia aims to further professionalize its members and concerned disciplines and is open to work with all relevant stakeholders towards a strong community of professionals in Belgium.
Apart from overall Healixia events there are events and trainings for each of the four Domains: regulatory (formerly by BRAS), medical (formerly by BeAPP), clinical research (formerly by ACRP.be) and early development (formerly by BAPU).
Healixia has a worldwide network of organisations with which we cooperate. Find out more about our Healixia network.
Download here our Healixia logo and a poster about 'The Belgian Healthcare Landscape'
An overview (you can download the infographic here):
If you have a question about Healixia, do not hesitate to contact us.
The Executive Board of Healixia has 2 representatives per Domain:
Healixia president
Erik Present
(Medical Affairs)
Benelux Medical Director at Galapagos
Healixia vice-president
Marian Coquel
(Regulatory Affairs)
Managing Director Regulatory Affairs & Quality at Infarama
Healixia board members
Annabelle Bruyndonckx
(Regulatory Affairs)
Partner Healthcare Life Sciences at Simmons & Simmons LLPDimitri Buytaert
(Clinical Research)
Global Head Clinical Operations at CellCartaJan de Hoon
(Early Development)
Professor in Pharmacology and Head of Department of the Center for Clinical Pharmacology at UZ LeuvenVeronique Lins
(Clinical Research)
Clinical Strategy and Innovation Lead Dengue, Global Public health at Janssen PharmaceuticaKoen Raeymaekers
(Medical Affairs)
Value Solutions Manager at AmgenSylvie Rottey
(Early Development)
Professor, Medical Oncologist & Clinical Pharmacologist, Head of Drug Research Unit Ghent and Head of Departement Medical Oncology at UZ Gent